The Europe Bone & Joint Health Supplements Market would witness market growth of 8.3% CAGR during the forecast period (2022-2028).
In addition to giving fruits their color, anthocyanins can also help reduce levels of C-reactive protein, a sign of inflammation. Antioxidants called polyphenols may lessen joint inflammation and delay cartilage deterioration. For rheumatoid arthritis patients who must take immunosuppressive drugs, they may also strengthen bones and aid in the body's ability to fight off infections.
According to studies, sulforaphane may inhibit the enzymes responsible for destroying joint cartilage and lessen inflammation. Patients with osteoarthritis may find both of these items to be quite beneficial. Diallyl disulfide may restrict the enzymes that damage cartilage. Individuals who consumed these items regularly showed fewer early osteoarthritis symptoms. To maintain a diet that supports bone and joint health, don't need to look for any unusual items. Additionally, these foods have a lot of other health advantages that make them worthwhile to include in the diet even if joint pain isn't a regular problem.
One in four people in Germany were obese in 2019, according to The Heavy Burden of Obesity, a report from the Organization for Economic Cooperation and Development (OECD). As a result, overweight people in Germany live two years less on average. As people's lives and food consumption habits change in industrialized countries, these numbers are anticipated to increase significantly. The prevalence of spinal issues and degenerative spinal disorders are both predicted to rise as a result of obesity. The growing cases of obese patients tend to weakness in the bones and joints which propels the adoption of Bone & joint health supplements in this region.
The Germany market dominated the Europe Bone & Joint Health Supplements Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,226.5 million by 2028. The UK market is anticipated to grow at a CAGR of 7.4% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 9.1% during (2022 - 2028).
Based on Target Consumers, the market is segmented into Elderly people, pregnant woman, Adults, Children and Infants. Based on Form, the market is segmented into Tablets, Capsules, Liquid, Powder and Others. Based on Type, the market is segmented into Vitamin D, Vitamin K, Calcium, Collagen, Omega-3 Fatty acids, Glucosamine-Chondroitin and Others. Based on Distribution Channel, the market is segmented into Supermarkets/hypermarkets, Pharmacies & Drug Stores and Health, Beauty Stores & Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Bone & Joint Health Supplements Market will Hit $19.3 Billion by 2028, at a CAGR of 9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include The Procter and Gamble Company, BASF SE, Amway Corporation, Pfizer, Inc., Glanbia PLC, Bayer AG, Archer Daniels Midland Company, Reckitt Benckiser Group PLC, Nutramax Laboratories, Inc., and NOW Foods, Inc.
By Target Consumers
By Form
By Type
By Distribution Channel
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 